201 related articles for article (PubMed ID: 16941999)
1. Endocrinologic manifestations of the antiphospholipid syndrome.
Uthman I; Salti I; Khamashta M
Lupus; 2006; 15(8):485-9. PubMed ID: 16941999
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid syndrome: endocrinologic manifestations and organ involvement.
Mehdi AA; Salti I; Uthman I
Semin Thromb Hemost; 2011 Feb; 37(1):49-57. PubMed ID: 21305801
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
5. Acute adrenal failure as the heralding symptom of primary antiphospholipid syndrome: report of a case and review of the literature.
Presotto F; Fornasini F; Betterle C; Federspil G; Rossato M
Eur J Endocrinol; 2005 Oct; 153(4):507-14. PubMed ID: 16189171
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid syndrome: 30 years and our contribution.
Koike T
Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
[TBL] [Abstract][Full Text] [Related]
7. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients.
Espinosa G; Santos E; Cervera R; Piette JC; de la Red G; Gil V; Font J; Couch R; Ingelmo M; Asherson RA
Medicine (Baltimore); 2003 Mar; 82(2):106-18. PubMed ID: 12640187
[TBL] [Abstract][Full Text] [Related]
8. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome.
Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F
Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162
[TBL] [Abstract][Full Text] [Related]
9. Adrenal involvement in the antiphospholipid syndrome.
Espinosa G; Cervera R; Font J; Asherson RA
Lupus; 2003; 12(7):569-72. PubMed ID: 12892401
[TBL] [Abstract][Full Text] [Related]
10. The abdominal manifestations of the antiphospholipid syndrome.
Uthman I; Khamashta M
Rheumatology (Oxford); 2007 Nov; 46(11):1641-7. PubMed ID: 17636180
[TBL] [Abstract][Full Text] [Related]
11. Primary antiphospholipid syndrome, Addison disease, and adrenal incidentaloma.
Medina G; Jiménez-Arellano MP; Muñoz-Solís A; Servín-Torres E; Ramírez-Mendoza P; Jara LJ
Clin Rheumatol; 2020 Jun; 39(6):1997-2001. PubMed ID: 32146613
[TBL] [Abstract][Full Text] [Related]
12. Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome.
Djokovic A; Stojanovich L; Kontic M; Stanisavljevic N; Radovanovic S; Marisavljevic D
Isr Med Assoc J; 2014 Mar; 16(3):162-7. PubMed ID: 24761704
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review].
Pons I; Espinosa G; Cervera R
Med Clin (Barc); 2015 Feb; 144(3):97-104. PubMed ID: 24698717
[TBL] [Abstract][Full Text] [Related]
15. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
16. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
18. Definitive bilateral adrenal failure in antiphospholipid syndrome.
Silvério RG; Caetano F; Gomes A; Sequeira M; Oliveira A
Acta Reumatol Port; 2012; 37(1):76-80. PubMed ID: 22781516
[TBL] [Abstract][Full Text] [Related]
19. Cardiac involvement in the antiphospholipid syndrome.
Tenedios F; Erkan D; Lockshin MD
Lupus; 2005; 14(9):691-6. PubMed ID: 16218469
[TBL] [Abstract][Full Text] [Related]
20. Ocular manifestations of the antiphospholipid syndrome.
Utz VM; Tang J
Br J Ophthalmol; 2011 Apr; 95(4):454-9. PubMed ID: 20693557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
